Cargando…
Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study
COVID19 in patients affected by lymphoma represents an important challenge because of the higher mortality rate. Anti‐SARS‐CoV‐2 monoclonal antibodies (anti‐S MoAbs) appear promising in this setting. We report a monocentric retrospective study including 176 patients affected by lymphoma which develo...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877821/ https://www.ncbi.nlm.nih.gov/pubmed/36521843 http://dx.doi.org/10.1002/hon.3113 |
Search Result 1
Enlace del recurso
por Assanto, Giovanni Manfredi, Di Rocco, Alice, Malfona, Francesco, Capriata, Marcello, Del Giudice, Ilaria, Petrucci, Luigi, Girardi, Paola, D'elia, Gianna Maria, Martelli, Maurizio, Gentile, Giuseppe, Micozzi, Alessandra, Pulsoni, Alessandro
Publicado 2022
Enlace del recurso
Publicado 2022
Enlace del recurso
Online
Artículo
Texto